Cargando…
Protocol-based cardiotoxicity monitoring in hydroxychloroquine medicated COVID-19 pediatric patients
INTRODUCTION/OBJECTIVES: By May 2020, SARS-CoV-2 had caused more than 400 000 deaths worldwide. Initially, hydroxychloroquine was a treatment option for COVID-19. More recent studies have questioned its safety and efficacy and, until stronger evidence is available, it was suspended from therapy prot...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455282/ https://www.ncbi.nlm.nih.gov/pubmed/34566257 http://dx.doi.org/10.1016/j.repc.2021.01.018 |